Celanese Corporation (CE): Monthly Stock Report

Publication Date: September 22, 2024

Company Overview

Celanese Corporation (NYSE: CE), based in Irving, Texas, is a leading entity within the chemicals industry, specifically focusing on the basic materials sector. Established in 1918, the company excels in producing and distributing high-performance engineered polymers worldwide. Celanese operates through two primary segments: Engineered Materials, which offers specialty polymers for automotive and medical applications, and the Acetyl Chain, which produces essential acetyl products utilized in colorants, adhesives, and pharmaceuticals. With a total revenue of approximately $10.55 billion, Celanese presents a compelling investment opportunity for those interested in specialty chemicals. As of now, the stock’s price is $126.90, trading below various projected targets, including a high estimated price of $178.00. Therefore, the current recommendation is to “hold,” allowing investors to maintain their positions while monitoring market developments.

Financial Performance and Market Dynamics

Celanese Corporation currently has 109,264,000 shares outstanding, with about 4,899,482 shares shorted, reflecting a short interest of around 7.04% of the total float. This relatively low short percentage indicates a moderate level of investor confidence in the company’s performance, even amid some skepticism. The stock’s current price points to substantial upside potential against analysts’ target metrics—while the mean target price stands at $149.11, the high target price predicts a potential surge to $178.00. Conversely, the low target price is pegged at $128.00, suggesting that while growth is possible, prudent investment strategies should be adopted. Given the stock’s recent price history, including a 52-week high of $172.16 and a low of $110.76, investors should monitor its performance closely as it trends closer to the lower end of this price range.

Outlook and Analyst Recommendations

Recent analyses indicate a mean recommendation score of 2.9 from 19 analysts, underscoring a moderate outlook reflected in a cautious hold strategy. The stock’s current trading price of $126.90 is beneath its 50-day moving average of $130.74, suggesting the possibility of a short-term downward trend. The analysts’ assessment illustrates a balanced view of the company’s current valuation, positioning Celanese as a stable investment within the chemical industry while advising investors to remain observant of market signals that may affect future price movements. As the market conditions evolve, Celanese’s strategic focus and solid revenue performance could pave the way for recovery and growth opportunities in the upcoming months.

Metric	Value
Market Cap	$13.9b
Total Debt	$13.4b
Total Cash	$1.2b
Shares Outstanding	109.3m
Float Shares	108.6m